Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Samrat Pharmachem

BSE: 530125|ISIN: INE103E01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 25, 10:07
77.80
2.65 (3.53%)
VOLUME 100
Samrat Pharmachem is not listed on NSE
Announcements on Samrat Pharma

20th-Apr-2017 15:46Source: BSE

Samrat Pharma- Compliance Certificate For The Period Ended March, 2017

Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the period ended March, 2017

18th-Apr-2017 14:44Source: BSE

Samrat Pharma- Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended March 31, 2017

Compliance Certificate under Regulation 40(9), (10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Half Year ended March 31, 2017

18th-Apr-2017 13:54Source: BSE

Samrat Pharma- Shareholding for the Period Ended March 31, 2017

Samrat Pharmachem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly

18th-Apr-2017 13:47Source: BSE

Samrat Pharma- Statement Of Investor Complaints For The Quarter Ended March, 2017

Statement of Investor Complaints for the Quarter ended March, 2017

14th-Apr-2017 15:42Source: BSE

Samrat Pharma- Closure of Trading Window

Closure of Trading Window for the f.t.y.e. 31/03/2017

14th-Apr-2017 15:40Source: BSE

Samrat Pharma- Board Meeting On May 30, 2017

Notice of Board Meeting for Audited Financial Results f.t.y.e. 31/03/2017

14th-Feb-2017 19:27Source: BSE

Samrat Pharma- Standalone Financial Results, Limited Review Report for December 31, 2016

Samrat Pharmachem Ltd has informed BSE about :

1. Standalone Financial Results for the period ended December 31, 2016

2. Standalone Limited Review for the period ended December 31, 2016

12th-Jan-2017 11:48Source: BSE

Samrat Pharma- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016

Samrat Pharmachem Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Li...

11th-Jan-2017 14:54Source: BSE

Samrat Pharma- Shareholding for the Period Ended December 31, 2016

Samrat Pharmachem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly

11th-Jan-2017 12:44Source: BSE

Samrat Pharma- Board Meeting Intimation for Results & Closure of Trading Window

Samrat Pharmachem Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 14, 2017, inter alia, to consider and take on record the Un-Audited Financial Re...

1 2 3 4 5 Next >>
Board Meeting (Samrat Pharma)

Meeting Date

Remark

2017-05-30

Audited Results

Quick Links for Samrat Pharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.